ASX - By Stock
|
WDS |
Re:
Ann: Dividend/Distribution - WDS
|
|
CJ0089
|
90 |
56K |
0 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
90
|
56K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
The Government has bought 3.5 million finger-prick antibody tests, but are they reliable? (UK)
|
|
CJ0089
|
12 |
5.1K |
0 |
03/05/20 |
03/05/20 |
ASX - By Stock
|
12
|
5.1K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
The Government has bought 3.5 million finger-prick antibody tests, but are they reliable? (UK)
|
|
CJ0089
|
12 |
5.1K |
0 |
03/05/20 |
03/05/20 |
ASX - By Stock
|
12
|
5.1K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo to present at Virtual Health Conference
|
|
CJ0089
|
87 |
35K |
2 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
87
|
35K
|
2
|
|
ASX - By Stock
|
GPT |
Re:
Ann: March Quarter Operational Update
|
|
CJ0089
|
2 |
1.4K |
2 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
2
|
1.4K
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
COVID-19
|
|
CJ0089
|
544 |
285K |
0 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
544
|
285K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
Potential SP Valuation of AT1 - 80 cents to 1.30/share
|
|
CJ0089
|
1.3K |
600K |
1 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
1.3K
|
600K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
COVID-19
|
|
CJ0089
|
544 |
285K |
3 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
544
|
285K
|
3
|
|
ASX - By Stock
|
AT1 |
Re:
Potential SP Valuation of AT1 - 80 cents to 1.30/share
|
|
CJ0089
|
1.3K |
600K |
4 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
1.3K
|
600K
|
4
|
|
ASX - By Stock
|
AT1 |
Re:
Potential SP Valuation of AT1 - 80 cents to 1.30/share
|
|
CJ0089
|
1.3K |
600K |
1 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
1.3K
|
600K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Potential SP Valuation of AT1 - 80 cents to 1.30/share
|
|
CJ0089
|
1.3K |
600K |
2 |
27/04/20 |
27/04/20 |
ASX - By Stock
|
1.3K
|
600K
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
COVID-19
|
|
CJ0089
|
544 |
285K |
4 |
26/04/20 |
26/04/20 |
ASX - By Stock
|
544
|
285K
|
4
|
|
ASX - By Stock
|
AT1 |
Re:
Potential SP Valuation of AT1 - 80 cents to 1.30/share
|
|
CJ0089
|
1.3K |
600K |
1 |
26/04/20 |
26/04/20 |
ASX - By Stock
|
1.3K
|
600K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
COVID-19
|
|
CJ0089
|
544 |
285K |
3 |
24/04/20 |
24/04/20 |
ASX - By Stock
|
544
|
285K
|
3
|
|
ASX - By Stock
|
AT1 |
Re:
50% margin ? The product
|
|
CJ0089
|
83 |
34K |
4 |
23/04/20 |
23/04/20 |
ASX - By Stock
|
83
|
34K
|
4
|
|
ASX - By Stock
|
AT1 |
Re:
50% margin ? The product
|
|
CJ0089
|
83 |
34K |
3 |
23/04/20 |
23/04/20 |
ASX - By Stock
|
83
|
34K
|
3
|
|
ASX - By Stock
|
AT1 |
Re:
50% margin ? The product
|
|
CJ0089
|
83 |
34K |
6 |
23/04/20 |
23/04/20 |
ASX - By Stock
|
83
|
34K
|
6
|
|
ASX - By Stock
|
AT1 |
Re:
COVID-19
|
|
CJ0089
|
544 |
285K |
6 |
21/04/20 |
21/04/20 |
ASX - By Stock
|
544
|
285K
|
6
|
|
ASX - By Stock
|
AT1 |
Re:
50% margin ? The product
|
|
CJ0089
|
83 |
34K |
5 |
21/04/20 |
21/04/20 |
ASX - By Stock
|
83
|
34K
|
5
|
|
ASX - By Stock
|
AT1 |
Re:
COVID-19
|
|
CJ0089
|
544 |
285K |
6 |
21/04/20 |
21/04/20 |
ASX - By Stock
|
544
|
285K
|
6
|
|
ASX - By Stock
|
AT1 |
Re:
50% margin ? The product
|
|
CJ0089
|
83 |
34K |
6 |
21/04/20 |
21/04/20 |
ASX - By Stock
|
83
|
34K
|
6
|
|